Drug
Sibeprenlimab
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Injection Site Discomfort | 7 | 47.1 | 48.2 | signal |
| 2 | Injection Site Swelling | 35 | 32.1 | 36.2 | signal |
| 3 | Injection Site Pruritus | 23 | 24.0 | 25.9 | signal |
| 4 | Injection Site Urticaria | 7 | 20.0 | 20.5 | signal |
| 5 | Injection Site Bruising | 17 | 15.0 | 15.8 | signal |
| 6 | Injection Site Rash | 6 | 13.7 | 14.0 | signal |
| 7 | Injection Site Pain | 42 | 9.6 | 11.0 | signal |
| 8 | Injection Site Erythema | 16 | 9.0 | 9.4 | signal |
| 9 | Incorrect Dose Administered By Device | 3 | 8.2 | 8.3 | signal |
| 10 | Device Difficult To Use | 7 | 7.4 | 7.5 | signal |
| 11 | Device Leakage | 4 | 6.6 | 6.6 | signal |
| 12 | Device Use Error | 3 | 6.1 | 6.2 | signal |